Holdings

Lion Point Capital, LP

As of Sep 30, 2026, Lion Point Capital, LP reported 30 positions worth US$14.6M. Largest: Cue Biopharma, Inc., Praxis Precision Medicines, Inc. and Fennec Pharmaceuticals Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Cue Biopharma, Inc.52,928US$1.37Mno changeSep 30, 2026
Praxis Precision Medicines, Inc.4,450US$1.3Mno changeSep 30, 2026
Fennec Pharmaceuticals Inc.112KUS$1.2Mno changeSep 30, 2026
COMPASS Pathways Plc80,000US$995KnewSep 30, 2026
Geron Corporation578KUS$711Kno changeSep 30, 2026
Milestone Pharmaceuticals Inc.820KUS$710Kno changeSep 30, 2026
Biohaven Ltd.51,700US$690Kno changeSep 30, 2026
Syndax Pharmaceuticals, Inc.36,000US$677Kno changeSep 30, 2026
Benitec Biopharma Inc.62,000US$620Kno changeSep 30, 2026
Disc Medicine, Inc.8,100US$530Kno changeSep 30, 2026